Zobrazit minimální záznam

Type 1 diabetes incidence increased during the COVID-19 pandemic years 2020-2021 in Czechia: results from a large population-based paediatric register

dc.contributor.authorCinek, Ondřej
dc.contributor.authorSlavenko, Matvei
dc.contributor.authorPomahačová, Renata
dc.contributor.authorVenháčová, Petra
dc.contributor.authorPetruželková, Lenka
dc.contributor.authorŠkvor, Jaroslav
dc.contributor.authorNeumann, David
dc.contributor.authorKonečná, Petra
dc.contributor.authorVosáhlo, Jan
dc.contributor.authorKocourková, Kamila
dc.contributor.authorStrnadel, Jiří
dc.contributor.authorPrůhová, Štěpánka
dc.contributor.authorŠumník, Zdeněk
dc.date.accessioned2023-01-20T08:28:03Z
dc.date.available2023-01-20T08:28:03Z
dc.date.issued2022
dc.identifier.urihttps://hdl.handle.net/20.500.14178/1649
dc.description.abstractOBJECTIVE: To explore type 1 diabetes incidence patterns during the pandemic years 2020 and 2021 in Czechia, to compare them to the trends from previous decade, and to test its association with indicators of containment measures and of pandemic severity (school closing and the all-cause excess mortality). RESEARCH DESIGN AND METODS: The Czech Childhood Diabetes Register is a population-based incidence register recording patients age 0-14.99 years at diabetes onset. Type 1 diabetes incidence in the pandemic period (April 2020 - end of observation Dec 2021) was compared by Poisson regression models to the incidence patterns over the past decade 2010-2019. RESULTS: During the pandemic years 2020-2021, 956 children 0-14.99 years old manifested with type 1 diabetes in Czechia. The observed incidence (27.2/100,000/year) was significantly higher than what was expected from the trends over 2010-2019 (incidence rate ratio, IRR = 1.16, 95%CI 1.06-1.28, P = 0.0022). The incidence had a trough during the first lockdown (March - May 2020), then it rose above expected values with no usual summer decrease. The assessed pandemic indicators (school closing and all-cause excess mortality) were not associated with the incidence levels. CONCLUSIONS: The COVID-19 pandemic was associated with a notable upward inflection of the type 1 diabetes incidence curve; the early months of the first lockdown were however hallmarked by a significant dip in new diabetes diagnoses. Long-term observation will show whether the increased incidence originated only from accelerating an advanced preclinical Stage 2 to overt diabetes, or whether the pandemic triggered new cases of islet autoimmunity.en
dc.language.isoen
dc.relation.urlhttps://doi.org/10.1111/pedi.13405
dc.rightsCreative Commons Uveďte původ-Neužívejte dílo komerčně 4.0 Internationalcs
dc.rightsCreative Commons Attribution-NonCommercial 4.0 Internationalen
dc.titleType 1 diabetes incidence increased during the COVID-19 pandemic years 2020-2021 in Czechia: results from a large population-based paediatric registeren
dcterms.accessRightsembargoedAccess
dcterms.licensehttps://creativecommons.org/licenses/by-nc/4.0/legalcode
dc.date.updated2023-10-02T06:13:57Z
dc.subject.keywordCOVID-19en
dc.subject.keywordincidence increaseen
dc.subject.keywordpandemicen
dc.subject.keywordtype 1 diabetesen
dc.relation.fundingReferenceinfo:eu-repo/grantAgreement/UK/COOP/COOP
dc.relation.fundingReferenceinfo:eu-repo/grantAgreement/FN/I-FN/I-FNM
dc.relation.fundingReferenceinfo:eu-repo/grantAgreement/UK/I-UK/I-LFP
dc.relation.fundingReferenceinfo:eu-repo/grantAgreement/FN/I-FN/I-FNP-42
dc.relation.fundingReferenceinfo:eu-repo/grantAgreement/FN/I-FN/I-FNHK
dc.relation.fundingReferenceinfo:eu-repo/grantAgreement/MSM//LX22NPO5103
dc.date.embargoStartDate2023-10-02
dc.date.embargoEndDate2022-08-18
dc.type.obd73
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.identifier.doi10.1111/pedi.13405
dc.identifier.utWos000849738500001
dc.identifier.eidScopus2-s2.0-85137679347
dc.identifier.obd613625
dc.identifier.rivRIV/00216208:11130/22:10445967
dc.identifier.rivRIV/00216208:11150/22:10445967
dc.identifier.rivRIV/00216208:11120/22:43923795
dc.identifier.rivRIV/00216208:11320/22:10445967
dc.identifier.rivRIV/00179906:_____/22:10445967
dc.identifier.rivRIV/00216208:11140/22:10445967
dc.identifier.pubmed35982508
dc.subject.rivPrimary30000::30200::30202
dc.subject.rivSecondary30000::30200::30209
dcterms.isPartOf.namePediatric Diabetes
dcterms.isPartOf.issn1399-543X
dcterms.isPartOf.journalYear2022
dcterms.isPartOf.journalVolume23
dcterms.isPartOf.journalIssue7
uk.faculty.primaryId109
uk.faculty.primaryName2. lékařská fakultacs
uk.faculty.primaryNameSecond Faculty of Medicineen
uk.faculty.secondaryId111
uk.faculty.secondaryId51
uk.faculty.secondaryId116
uk.faculty.secondaryId110
uk.faculty.secondaryId52
uk.faculty.secondaryId112
uk.faculty.secondaryNameLékařská fakulta v Plznics
uk.faculty.secondaryNameFaculty of Medicine in Pilsenen
uk.faculty.secondaryNameFakultní nemocnice Hradec Královécs
uk.faculty.secondaryNameUniversity Hospital Hradec Královéen
uk.faculty.secondaryNameMatematicko-fyzikální fakultacs
uk.faculty.secondaryNameFaculty of Mathematics and Physicsen
uk.faculty.secondaryName3. lékařská fakultacs
uk.faculty.secondaryNameThird Faculty of Medicineen
uk.faculty.secondaryNameFakultní nemocnice v Motolecs
uk.faculty.secondaryNameMotol University Hospitalen
uk.faculty.secondaryNameLékařská fakulta v Hradci Královécs
uk.faculty.secondaryNameFaculty of Medicine in Hradec Kraloveen
uk.department.primaryId109
uk.department.primaryName2. lékařská fakultacs
uk.department.primaryNameSecond Faculty of Medicineen
uk.department.secondaryId1395
uk.department.secondaryId100010693530
uk.department.secondaryId696
uk.department.secondaryId606
uk.department.secondaryId1685
uk.department.secondaryId5000000001
uk.department.secondaryId1314
uk.department.secondaryNameDětská klinikacs
uk.department.secondaryNameDepartment of Paediatricsen
uk.department.secondaryNamePediatrická klinika 2. LF UK a FN Motolcs
uk.department.secondaryNameDepartment of Paediatrics, 2nd Faculty of Medicine and Motol University Hospitalen
uk.department.secondaryNameDětská klinikacs
uk.department.secondaryNameDepartment of Pediatricsen
uk.department.secondaryNameKlinika dětí a dorostu 3. LF UK a FNKVcs
uk.department.secondaryNameDepartment of Children and Adolescents 3FM CU and UHKVen
uk.department.secondaryNamePediatrická klinikacs
uk.department.secondaryNamePediatrická klinikaen
uk.department.secondaryNameDětská klinikacs
uk.department.secondaryNameDepartment of Pediatricsen
uk.department.secondaryNameKatedra pravděpodobnosti a matematické statistikycs
uk.department.secondaryNameDepartment of Probability and Mathematical Statisticsen
dc.description.pageRange956-960
dc.type.obdHierarchyCsČLÁNEK V ČASOPISU::článek v časopisu::původní článekcs
dc.type.obdHierarchyEnJOURNAL ARTICLE::journal article::original articleen
dc.type.obdHierarchyCode73::152::206en
uk.displayTitleType 1 diabetes incidence increased during the COVID-19 pandemic years 2020-2021 in Czechia: results from a large population-based paediatric registeren


Soubory tohoto záznamu

Thumbnail

Tento záznam se objevuje v následujících kolekcích

Zobrazit minimální záznam